SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-19-000044
Filing Date
2019-11-08
Accepted
2019-11-08 17:06:56
Documents
93
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20190930x10q.htm 10-Q 2973844
2 EX-31.1 amph-20190930ex3110f2f0d.htm EX-31.1 22857
3 EX-31.2 amph-20190930ex31283b62f.htm EX-31.2 22977
4 EX-32.1 amph-20190930ex321c8dbf0.htm EX-32.1 12344
5 EX-32.2 amph-20190930ex322bd08e3.htm EX-32.2 12312
  Complete submission text file 0001297184-19-000044.txt   12052828

Data Files

Seq Description Document Type Size
6 EX-101.INS amph-20190930.xml EX-101.INS 3238255
7 EX-101.SCH amph-20190930.xsd EX-101.SCH 67375
8 EX-101.CAL amph-20190930_cal.xml EX-101.CAL 80968
9 EX-101.DEF amph-20190930_def.xml EX-101.DEF 208851
10 EX-101.LAB amph-20190930_lab.xml EX-101.LAB 506841
11 EX-101.PRE amph-20190930_pre.xml EX-101.PRE 441137
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 191204875
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences